141 related articles for article (PubMed ID: 10076998)
1. A novel method for analysis of nuclear receptor function at natural promoters: peroxisome proliferator-activated receptor gamma agonist actions on aP2 gene expression detected using branched DNA messenger RNA quantitation.
Burris TP; Pelton PD; Zhou L; Osborne MC; Cryan E; Demarest KT
Mol Endocrinol; 1999 Mar; 13(3):410-7. PubMed ID: 10076998
[TBL] [Abstract][Full Text] [Related]
2. Inflammatory mechanisms in Alzheimer's disease: inhibition of beta-amyloid-stimulated proinflammatory responses and neurotoxicity by PPARgamma agonists.
Combs CK; Johnson DE; Karlo JC; Cannady SB; Landreth GE
J Neurosci; 2000 Jan; 20(2):558-67. PubMed ID: 10632585
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of RXR and PPARgamma ameliorates diet-induced obesity and type 2 diabetes.
Yamauchi T; Waki H; Kamon J; Murakami K; Motojima K; Komeda K; Miki H; Kubota N; Terauchi Y; Tsuchida A; Tsuboyama-Kasaoka N; Yamauchi N; Ide T; Hori W; Kato S; Fukayama M; Akanuma Y; Ezaki O; Itai A; Nagai R; Kimura S; Tobe K; Kagechika H; Shudo K; Kadowaki T
J Clin Invest; 2001 Oct; 108(7):1001-13. PubMed ID: 11581301
[TBL] [Abstract][Full Text] [Related]
4. Fatty acids and hypolipidemic drugs regulate peroxisome proliferator-activated receptors alpha - and gamma-mediated gene expression via liver fatty acid binding protein: a signaling path to the nucleus.
Wolfrum C; Borrmann CM; Borchers T; Spener F
Proc Natl Acad Sci U S A; 2001 Feb; 98(5):2323-8. PubMed ID: 11226238
[TBL] [Abstract][Full Text] [Related]
5. Peroxisome proliferator-activated receptor gamma-dependent repression of the inducible nitric oxide synthase gene.
Li M; Pascual G; Glass CK
Mol Cell Biol; 2000 Jul; 20(13):4699-707. PubMed ID: 10848596
[TBL] [Abstract][Full Text] [Related]
6. Effects of peroxisome proliferator-activated receptor-alpha and -gamma agonist, JTT-501, on diabetic complications in Zucker diabetic fatty rats.
Shibata T; Takeuchi S; Yokota S; Kakimoto K; Yonemori F; Wakitani K
Br J Pharmacol; 2000 Jun; 130(3):495-504. PubMed ID: 10821776
[TBL] [Abstract][Full Text] [Related]
7. Adipose tissue is required for the antidiabetic, but not for the hypolipidemic, effect of thiazolidinediones.
Chao L; Marcus-Samuels B; Mason MM; Moitra J; Vinson C; Arioglu E; Gavrilova O; Reitman ML
J Clin Invest; 2000 Nov; 106(10):1221-8. PubMed ID: 11086023
[TBL] [Abstract][Full Text] [Related]
8. A peroxisome proliferator-activated receptor gamma ligand inhibits adipocyte differentiation.
Oberfield JL; Collins JL; Holmes CP; Goreham DM; Cooper JP; Cobb JE; Lenhard JM; Hull-Ryde EA; Mohr CP; Blanchard SG; Parks DJ; Moore LB; Lehmann JM; Plunket K; Miller AB; Milburn MV; Kliewer SA; Willson TM
Proc Natl Acad Sci U S A; 1999 May; 96(11):6102-6. PubMed ID: 10339548
[TBL] [Abstract][Full Text] [Related]
9. Isolation of the human peroxisome proliferator activated receptor gamma cDNA: expression in hematopoietic cells and chromosomal mapping.
Greene ME; Blumberg B; McBride OW; Yi HF; Kronquist K; Kwan K; Hsieh L; Greene G; Nimer SD
Gene Expr; 1995; 4(4-5):281-99. PubMed ID: 7787419
[TBL] [Abstract][Full Text] [Related]
10. In vitro Screening and Evaluation of 37 Traditional Chinese Medicines for Their Potential to Activate Peroxisome Proliferator-Activated Receptors-γ.
Gao D; Zhang Y; Yang F; Lin Y; Zhang Q; Xia Z
Pharmacogn Mag; 2016; 12(46):120-7. PubMed ID: 27076748
[TBL] [Abstract][Full Text] [Related]
11. Imaging and peroxisome proliferator-activated receptor agonists: uncovering their role in atherosclerosis development.
Nissen SE
Clin Cardiol; 2004 Jul; 27(7 Suppl 4):IV17-20. PubMed ID: 15470907
[TBL] [Abstract][Full Text] [Related]
12. Expression, purification, crystallization and structure of human adipocyte lipid-binding protein (aP2).
Marr E; Tardie M; Carty M; Brown Phillips T; Wang IK; Soeller W; Qiu X; Karam G
Acta Crystallogr Sect F Struct Biol Cryst Commun; 2006 Nov; 62(Pt 11):1058-60. PubMed ID: 17077479
[TBL] [Abstract][Full Text] [Related]
13. Tributyltin perturbs femoral cortical architecture and polar moment of inertia in rat.
Li M; Cheng D; Li H; Yao W; Guo D; Wang S; Si J
BMC Musculoskelet Disord; 2021 May; 22(1):427. PubMed ID: 33962613
[TBL] [Abstract][Full Text] [Related]
14. Effects of the cholesteryl ester transfer protein inhibitor evacetrapib on lipoproteins, apolipoproteins and 24-h ambulatory blood pressure in healthy adults.
Suico JG; Wang MD; Friedrich S; Cannady EA; Konkoy CS; Ruotolo G; Krueger KA
J Pharm Pharmacol; 2014 Nov; 66(11):1576-85. PubMed ID: 24961753
[TBL] [Abstract][Full Text] [Related]
15. Targeted siRNA Delivery and mRNA Knockdown Mediated by Bispecific Digoxigenin-binding Antibodies.
Schneider B; Grote M; John M; Haas A; Bramlage B; Ickenstein LM; Jahn-Hofmann K; Bauss F; Cheng W; Croasdale R; Daub K; Dill S; Hoffmann E; Lau W; Burtscher H; Ludtke JL; Metz S; Mundigl O; Neal ZC; Scheuer W; Stracke J; Herweijer H; Brinkmann U
Mol Ther Nucleic Acids; 2012 Sep; 1(9):e46. PubMed ID: 23344238
[TBL] [Abstract][Full Text] [Related]
16. Transgenerational inheritance of increased fat depot size, stem cell reprogramming, and hepatic steatosis elicited by prenatal exposure to the obesogen tributyltin in mice.
Chamorro-García R; Sahu M; Abbey RJ; Laude J; Pham N; Blumberg B
Environ Health Perspect; 2013 Mar; 121(3):359-66. PubMed ID: 23322813
[TBL] [Abstract][Full Text] [Related]
17. Triflumizole is an obesogen in mice that acts through peroxisome proliferator activated receptor gamma (PPARγ).
Li X; Pham HT; Janesick AS; Blumberg B
Environ Health Perspect; 2012 Dec; 120(12):1720-6. PubMed ID: 23086663
[TBL] [Abstract][Full Text] [Related]
18. Evacetrapib is a novel, potent, and selective inhibitor of cholesteryl ester transfer protein that elevates HDL cholesterol without inducing aldosterone or increasing blood pressure.
Cao G; Beyer TP; Zhang Y; Schmidt RJ; Chen YQ; Cockerham SL; Zimmerman KM; Karathanasis SK; Cannady EA; Fields T; Mantlo NB
J Lipid Res; 2011 Dec; 52(12):2169-2176. PubMed ID: 21957197
[TBL] [Abstract][Full Text] [Related]
19. Tools for the identification of bioactives impacting the metabolic syndrome: screening of a botanical extract library using subcutaneous and visceral human adipose-derived stem cell-based assays.
Buehrer BM; Duffin DJ; Lea-Currie YR; Ribnicky D; Raskin I; Stephens JM; Cefalu WT; Gimble JM
J Nutr Biochem; 2012 Jun; 23(6):519-25. PubMed ID: 21543201
[TBL] [Abstract][Full Text] [Related]
20. Prenatal exposure to the environmental obesogen tributyltin predisposes multipotent stem cells to become adipocytes.
Kirchner S; Kieu T; Chow C; Casey S; Blumberg B
Mol Endocrinol; 2010 Mar; 24(3):526-39. PubMed ID: 20160124
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
